SEC 13F Intelligence

M28 Capital Management LP / MRTXEUR

M28 Capital Management LP’s Mirati Therapeutics Inc Position

Does M28 Capital Management LP own Mirati Therapeutics Inc (MRTXEUR)? Not currently — the last reported position was 61.2K shares worth $4M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q3 2022
Shares
61.2K
% of Portfolio
+4.46%
Quarters Held
4
position exited

Position History MRTXEUR

Reported value by quarter
Q4 ’21: $3MQ4 ’21Q1 ’22: $7MQ1 ’22Q2 ’22: $4MQ2 ’22Q3 ’22: $4MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202261.2K$4M+4.46%
Q2 202261.2K$4M+4.61%
Q1 202282.9K$7M+6.27%
Q4 202119.2K$3M+2.20%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See M28 Capital Management LP’s full portfolio or all institutional holders of MRTXEUR.